- Home
- QUBT vs FOLD Comparison
QUBT vs FOLD Comparison
Compare QUBT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- FOLD
- Stock Information
- Founded
- QUBT 2001
- FOLD 2002
- Country
- QUBT United States
- FOLD United States
- Employees
- QUBT N/A
- FOLD N/A
- Industry
- QUBT Computer Manufacturing
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- FOLD Health Care
- Exchange
- QUBT Nasdaq
- FOLD Nasdaq
- Market Cap
- QUBT 2.7B
- FOLD 2.5B
- IPO Year
- QUBT N/A
- FOLD 2007
- Fundamental
- Price
- QUBT $19.98
- FOLD $8.25
- Analyst Decision
- QUBT Strong Buy
- FOLD Strong Buy
- Analyst Count
- QUBT 3
- FOLD 9
- Target Price
- QUBT $20.33
- FOLD $26.44
- AVG Volume (30 Days)
- QUBT 36.3M
- FOLD 5.5M
- Earning Date
- QUBT 11-05-2025
- FOLD 11-05-2025
- Dividend Yield
- QUBT N/A
- FOLD N/A
- EPS Growth
- QUBT N/A
- FOLD N/A
- EPS
- QUBT N/A
- FOLD N/A
- Revenue
- QUBT $263,000.00
- FOLD $571,160,000.00
- Revenue This Year
- QUBT $23.06
- FOLD $20.98
- Revenue Next Year
- QUBT $311.11
- FOLD $20.74
- P/E Ratio
- QUBT N/A
- FOLD N/A
- Revenue Growth
- QUBT N/A
- FOLD 25.35
- 52 Week Low
- QUBT $0.65
- FOLD $5.51
- 52 Week High
- QUBT $27.15
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- QUBT 57.53
- FOLD 57.08
- Support Level
- QUBT $18.00
- FOLD $7.68
- Resistance Level
- QUBT $23.44
- FOLD $8.44
- Average True Range (ATR)
- QUBT 2.18
- FOLD 0.41
- MACD
- QUBT -0.04
- FOLD -0.07
- Stochastic Oscillator
- QUBT 51.34
- FOLD 59.81
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.